Comparison of postoperative adjuvant therapy for early-stage cervical cancer: A surveillance, epidemiology, and end results analysis
No significant differences in OS and CCSS were observed among the three histological subtypes. The prognosis of ASC patients who received CRT was better than that of those who received RT alone. Patients with stage I tumors could obtain better survival with RT alone. The addition of brachytherapy to EBRT yielded no benefits across the three histological subtypes.
Authors
- Yu Bai (ORCID: https://orcid.org/0000-0001-6732-186X)
- Chuntang Sun
- Le Zhou (ORCID: https://orcid.org/0000-0001-5891-4145)
- Peng Diao (ORCID: https://orcid.org/0009-0000-1097-1394)
- Shuai Zeng
Institutions
- Peking University (CN)
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
- Sichuan Cancer Hospital (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2025-09-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_2085_24
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00